Recruiting
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.
Identifying women at risk for hereditary cancer potentiates prevention, early detection or personalised treatment against cancer. We using mobile mammography units will provide genetic sceening and testing services to underserved women coming for thier mammograms to these units.
ClinicalTrials.gov IDNCT05649072
PhaseNA
Enrollment1000
SponsorM.D. Anderson Cancer Center
Age18 Years
SexFEMALE
Conditions studied
Ovarian Cancer, Breast Cancer, Colorectal Cancer
About this study
Identifying women at risk for hereditary cancer potentiates prevention, early detection or personalised treatment against cancer. We using mobile mammography units will provide genetic sceening and testing services to underserved women coming for thier mammograms to these units.
Interventions
- Behavioral: Genetic Testing and Counseling — Participants will be asked to collect a saliva sample for hereditary cancer and genetic testing
- Behavioral: Screening Form — Participant will be answering demographic details
Primary outcomes
- To identify underserved women at risk for hereditary breast and colorectal cancers eligible for standard-of-care genetic counseling using national screening guidelines. (through study completion; an average of 1 year.)
Eligibility information
Inclusion Criteria:
Any woman scheduled at Project VALET mammography screening mobile units will be eligible for this study.
Exclusion Criteria:
Study locations
- M D Anderson Cancer Center, Houston, Texas 77030 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.